IDEAS home Printed from https://ideas.repec.org/r/mit/sloanp/2523.html
   My bibliography  Save this item

The evolution of integrative capability : innovation in cardiovascular drug discovery

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Nicolai J. Foss, 1996. "Firms, Incomplete Contracts and Organizational Learning," DRUID Working Papers 96-2, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
  2. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni & Andrea Bonaccorsi & Giuseppe Turchetti, 1997. "The Evolution of Knowledge and the Dynamics of an Industry Network," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 1(2), pages 147-175, June.
  3. Rebecca Henderson & Iain Cockburn, 1994. "Measuring Competence? Exploring Firm Effects in Pharmaceutical Research," Strategic Management Journal, Wiley Blackwell, vol. 15(S1), pages 63-84, December.
  4. Mario Coccia, 2017. "Disruptive technologies and competitive advantage of firms in dynamic markets," IRCrES Working Paper 201704, CNR-IRCrES Research Institute on Sustainable Economic Growth - Moncalieri (TO) ITALY - former Institute for Economic Research on Firms and Growth - Torino (TO) ITALY.
  5. Helfat, Constance E. & Raubitschek, Ruth S., 2018. "Dynamic and integrative capabilities for profiting from innovation in digital platform-based ecosystems," Research Policy, Elsevier, vol. 47(8), pages 1391-1399.
  6. Dominique Perrochon & Didier Lebert, 2000. "L'utilisation des notions de confiance et de proximité dans l'étude des processus de R&D pharmaceutiques," Cahiers de la Maison des Sciences Economiques r00056, Université Panthéon-Sorbonne (Paris 1).
  7. Dibiaggio, Ludovic & Nasiriyar, Maryam & Nesta, Lionel, 2014. "Substitutability and complementarity of technological knowledge and the inventive performance of semiconductor companies," Research Policy, Elsevier, vol. 43(9), pages 1582-1593.
  8. Jongwook Kim & Joseph T. Mahoney, 2002. "Resource-based and property rights perspectives on value creation: the case of oil field unitization," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 23(4-5), pages 225-245.
  9. Mario Coccia, 2017. "Disruptive firms," Papers 1710.06132, arXiv.org.
  10. repec:dau:papers:123456789/4322 is not listed on IDEAS
  11. Michael Lenox, 2002. "Organizational Design, Information Transfer, and the Acquisition of Rent-Producing Resources," Computational and Mathematical Organization Theory, Springer, vol. 8(2), pages 113-131, July.
  12. Ryan Bubb & Patrick L. Warren, 2014. "Optimal Agency Bias and Regulatory Review," The Journal of Legal Studies, University of Chicago Press, vol. 43(1), pages 95-135.
  13. Pettus, Michael L. & Kor, Yasemin Y. & Mahoney, Joseph T., 2007. "A Theory of Change in Turbulent Environments: The Sequencing of Dynamic Capabilities Following Industry Deregulation," Working Papers 07-0100, University of Illinois at Urbana-Champaign, College of Business.
  14. Swan, Jacky & Goussevskaia, Anna & Newell, Sue & Robertson, Maxine & Bresnen, Mike & Obembe, Ademola, 2007. "Modes of organizing biomedical innovation in the UK and US and the role of integrative and relational capabilities," Research Policy, Elsevier, vol. 36(4), pages 529-547, May.
  15. Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005. "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 14(5), pages 395-415.
  16. Gilbert, Brett Anitra & McDougall, Patricia P. & Audretsch, David B., 2008. "Clusters, knowledge spillovers and new venture performance: An empirical examination," Journal of Business Venturing, Elsevier, vol. 23(4), pages 405-422, July.
  17. Zhang, Jing & Baden-Fuller, Charles & Mangematin, Vincent, 2007. "Technological knowledge base, R&D organization structure and alliance formation: Evidence from the biopharmaceutical industry," Research Policy, Elsevier, vol. 36(4), pages 515-528, May.
  18. Darius Sargautis, 2014. "Increasing Bioethanol Producers’ Technological Innovation Capacity Through R&D Organisation," SBS Journal of Applied Business Research (SBS-JABR), SBS Swiss Business School, vol. 3, pages 7-27.
  19. Turanay Caner & Susan K. Cohen & Frits Pil, 2017. "Firm heterogeneity in complex problem solving: A knowledge-based look at invention," Strategic Management Journal, Wiley Blackwell, vol. 38(9), pages 1791-1811, September.
  20. Mario Coccia, 2012. "Path-breaking innovations for lung cancer: a revolution in clinical practice," CERIS Working Paper 201201, CNR-IRCrES Research Institute on Sustainable Economic Growth - Torino (TO) ITALY - former Institute for Economic Research on Firms and Growth - Moncalieri (TO) ITALY.
  21. Hazhir Rahmandad, 2012. "Impact of Growth Opportunities and Competition on Firm-Level Capability Development Trade-offs," Organization Science, INFORMS, vol. 23(1), pages 138-154, February.
  22. Lihong Qian & Rajshree Agarwal & Glenn Hoetker, 2012. "Configuration of Value Chain Activities: The Effect of Pre-Entry Capabilities, Transaction Hazards, and Industry Evolution on Decisions to Internalize," Organization Science, INFORMS, vol. 23(5), pages 1330-1349, October.
  23. Nicolai J Foss & Jens Frøslev Christensen, 2001. "A market-process approach to corporate coherence," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 22(4-5), pages 213-226.
  24. Thomke, Stefan & von Hippel, Eric & Franke, Roland, 1998. "Modes of experimentation: an innovation process--and competitive--variable," Research Policy, Elsevier, vol. 27(3), pages 315-332, July.
  25. repec:dau:papers:123456789/3109 is not listed on IDEAS
  26. Gilsing, V.A. & Nooteboom, B., 2004. "Co-evolution in innovation systems: the case of pharmaceutical biotechnology," Working Papers 04.09, Eindhoven Center for Innovation Studies.
  27. Rauniar, Rupak & Doll, William & Rawski, Greg & Hong, Paul, 2008. "Shared knowledge and product design glitches in integrated product development," International Journal of Production Economics, Elsevier, vol. 114(2), pages 723-736, August.
  28. Roach, Michael & Sauermann, Henry, 2010. "A taste for science? PhD scientists' academic orientation and self-selection into research careers in industry," Research Policy, Elsevier, vol. 39(3), pages 422-434, April.
  29. Steven Casper & Catherine Matraves, 1997. "Corporate Governance and Firm Strategy in the Pharmaceutical Industry," CIG Working Papers FS IV 97-20, Wissenschaftszentrum Berlin (WZB), Research Unit: Competition and Innovation (CIG).
  30. Billette de Villemeur, Etienne & Versaevel, Bruno, 2019. "One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry," Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
  31. Wang, I. Kim & Seidle, Russell, 2020. "Ambition in innovation: Vicarious learning in the nascent electric scooter market in Taiwan," Technological Forecasting and Social Change, Elsevier, vol. 152(C).
  32. Jing Zhang & Charles Baden‐Fuller, 2010. "The Influence of Technological Knowledge Base and Organizational Structure on Technology Collaboration," Journal of Management Studies, Wiley Blackwell, vol. 47(4), pages 679-704, June.
  33. Oliver Schilke & Bernd W. Wirtz, 2008. "Allianzfähigkeit — Eine Analyse zur Operationalisierung und Erfolgswirkung im Kontext von F&E-Allianzen," Schmalenbach Journal of Business Research, Springer, vol. 60(5), pages 479-516, August.
  34. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni, 1999. "Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry," LEM Papers Series 1999/13, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  35. Sobrero, Maurizio & Roberts, Edward B., 2002. "Strategic management of supplier-manufacturer relations in new product development," Research Policy, Elsevier, vol. 31(1), pages 159-182, January.
  36. Coccia M., 2014. "Lab-oriented radical innovations as drivers of paradigm shifts in science," MERIT Working Papers 2014-090, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  37. Azoulay, Pierre & Heggeness, Misty & Kao, Jennifer, 2025. "Medical research and health care finance: Evidence from Academic Medical Centers," Research Policy, Elsevier, vol. 54(2).
  38. Mario COCCIA, 2017. "Disruptive firms and industrial change," Journal of Economic and Social Thought, KSP Journals, vol. 4(4), pages 437-450, December.
  39. Marco Iansiti, 2000. "How the Incumbent Can Win: Managing Technological Transitions in the Semiconductor Industry," Management Science, INFORMS, vol. 46(2), pages 169-185, February.
  40. Michael Lenox, 1998. "Organizational Design and the Acquisition of Rent-Producing Resources," Research in Economics 98-06-051e, Santa Fe Institute.
  41. Jing Zhang & Charles Baden-Fuller & Vincent Mangematin, 2007. "Technological Knowledge Base, R&D Organization Structure and Alliance Formation: Evidence from the Biopharmaceutical Industry," Post-Print hal-00424512, HAL.
  42. Christian Stadler & Constance E. Helfat & Gianmario Verona, 2013. "The Impact of Dynamic Capabilities on Resource Access and Development," Organization Science, INFORMS, vol. 24(6), pages 1782-1804, December.
  43. Laura B. Cardinal, 2001. "Technological Innovation in the Pharmaceutical Industry: The Use of Organizational Control in Managing Research and Development," Organization Science, INFORMS, vol. 12(1), pages 19-36, February.
  44. Henry Sauermann & Wesley M. Cohen, 2010. "What Makes Them Tick? Employee Motives and Firm Innovation," Management Science, INFORMS, vol. 56(12), pages 2134-2153, December.
  45. A. Leiponen, 1997. "Dynamic Competences and Firm Performance," Working Papers ir97006, International Institute for Applied Systems Analysis.
  46. Gilsing, Victor & Nooteboom, Bart, 2006. "Exploration and exploitation in innovation systems: The case of pharmaceutical biotechnology," Research Policy, Elsevier, vol. 35(1), pages 1-23, February.
  47. Toole, Andrew A., 2012. "The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry," Research Policy, Elsevier, vol. 41(1), pages 1-12.
  48. Thomke, Stefan H. & Hippel, Eric von. & Franke, Roland Rolf., 1997. "Modes of experimentation : an innovation process, and competitive, variable," Working papers WP 3972-97., Massachusetts Institute of Technology (MIT), Sloan School of Management.
  49. Jean Guillaume Forand & Jan Zapal, 2017. "The Demand and Supply of Favours in Dynamic Relationships," Working Papers 1705, University of Waterloo, Department of Economics, revised Sep 2017.
  50. Tetlock, Philip E. & Vieider, Ferdinand M. & Patil, Shefali V. & Grant, Adam M., 2013. "Accountability and ideology: When left looks right and right looks left," Organizational Behavior and Human Decision Processes, Elsevier, vol. 122(1), pages 22-35.
  51. Robert Gibbons & Rebecca Henderson, 2012. "Relational Contracts and Organizational Capabilities," Organization Science, INFORMS, vol. 23(5), pages 1350-1364, October.
  52. Toole, Andrew A., 2011. "The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry," ZEW Discussion Papers 11-063, ZEW - Leibniz Centre for European Economic Research.
  53. Constance E. Helfat & Miguel A. Campo-Rembado, 2016. "Integrative Capabilities, Vertical Integration, and Innovation Over Successive Technology Lifecycles," Organization Science, INFORMS, vol. 27(2), pages 249-264, April.
  54. Casper, Steven & Matraves, Catherine, 2003. "Institutional frameworks and innovation in the German and UK pharmaceutical industry," Research Policy, Elsevier, vol. 32(10), pages 1865-1879, December.
  55. Anokhin, Sergey & Wincent, Joakim & Oghazi, Pejvak, 2016. "Strategic effects of corporate venture capital investments," Journal of Business Venturing Insights, Elsevier, vol. 5(C), pages 63-69.
  56. Baba, Yasunori & Walsh, John P., 2010. "Embeddedness, social epistemology and breakthrough innovation: The case of the development of statins," Research Policy, Elsevier, vol. 39(4), pages 511-522, May.
  57. Kenneth Zahringer & Christos Kolympiris & Nicholas Kalaitzandonakes, 2017. "Academic knowledge quality differentials and the quality of firm innovation," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 26(5), pages 821-844.
  58. Orsenigo, L. & Pammolli, F. & Riccaboni, Massimo, 2001. "Technological change and network dynamics: Lessons from the pharmaceutical industry," Research Policy, Elsevier, vol. 30(3), pages 485-508, March.
  59. Tianxu Chen & Lihong Qian & Vadake Narayanan, 2017. "Battle on the Wrong Field? Entrant Type, Dominant Designs, and Technology Exit," Strategic Management Journal, Wiley Blackwell, vol. 38(13), pages 2579-2598, December.
  60. Baier , Elisabeth & Rammer , Christian & Schubert , Torben, 2013. "The Impact of Innovation Off-shoring on Organizational Adaptability," Papers in Innovation Studies 2013/44, Lund University, CIRCLE - Centre for Innovation Research.
  61. Stefano Brusoni & Lorenzo Cassi, 2007. "Re-Inventing the Wheel: Knowledge Integration in Fast-changing Environments," KITeS Working Papers 209, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Dec 2007.
  62. Ugo Rizzo & Francesco Nicolli & Laura Ramaciotti, 2014. "The Heterogeneity of the Development Process of New Technology-Based Firms. Implication for Innovation Policies," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 5(1), pages 114-132, March.
  63. Aharonson, Barak S. & Schilling, Melissa A., 2016. "Mapping the technological landscape: Measuring technology distance, technological footprints, and technology evolution," Research Policy, Elsevier, vol. 45(1), pages 81-96.
  64. Jong, Simcha & Slavova, Kremena, 2014. "When publications lead to products: The open science conundrum in new product development," Research Policy, Elsevier, vol. 43(4), pages 645-654.
  65. Franco Malerba & Luigi Orsenigo, 2000. "Towards a History Friendly Model of Innovation, Market Structure and Regulation in the Dynamics of the Pharmaceutical Industry: the Age of Random Screening," KITeS Working Papers 124, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Jan 2001.
  66. Kamrun Nahar Munny & Mostak Ahamed Galib & Ding Lin, 2015. "Scientists Collaborating with Industry: An Exploration of Industry Engagement Types," International Journal of Management Science and Business Administration, Inovatus Services Ltd., vol. 1(8), pages 37-46, July.
  67. Malerba, Franco, 2002. "Sectoral systems of innovation and production," Research Policy, Elsevier, vol. 31(2), pages 247-264, February.
  68. Steven Postrel, 2002. "Islands of Shared Knowledge: Specialization and Mutual Understanding in Problem-Solving Teams," Organization Science, INFORMS, vol. 13(3), pages 303-320, June.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.